Abnormally reduced frontal cortex activity during Trail-Making-Test in prodromal parkinson's disease-a fNIRS study.


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
09 2021
Historique:
received: 15 05 2020
revised: 16 04 2021
accepted: 20 04 2021
pubmed: 5 6 2021
medline: 24 12 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Parkinson's Disease (PD) is a neurodegenerative disorder leading to typical motor as well as a range of non-motor symptoms, including cognitive decline mainly characterized by executive deficits. The latter are known to appear years before the typical motor signs, thus representing the prodromal phase of PD. However, appropriate methods for measuring executive dysfunction in this context are not well established yet. Traditionally, executive performance is associated with frontal structures. Here, we investigated prodromal, early PD patients and healthy controls regarding their executive functioning on the behavioral and neural level, measured by the Trail-Making-Test (TMT) combined with functional near-infrared spectroscopy. We observed significantly reduced neural activity in the right dorsolateral prefrontal cortex within PD patients compared to controls completing the TMT-A and -B in contrast to the TMT-C, but no differences on a behavioral level. These promising results need to be confirmed and checked for reliability in future studies to extend the spectrum of markers applied in prodromal PD.

Identifiants

pubmed: 34087607
pii: S0197-4580(21)00130-5
doi: 10.1016/j.neurobiolaging.2021.04.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-158

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Anna Hofmann (A)

Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany; German Center of Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany. Electronic address: anna.hofmann@med.uni-tuebingen.de.

David Rosenbaum (D)

Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.

Isabell Int-Veen (I)

Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.

Ann-Christine Ehlis (AC)

Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.

Kathrin Brockmann (K)

Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany; German Center of Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Katja Dehnen (K)

Institute for General Medicine, University Hospital of Essen, Essen, Germany.

Anna-Katharina von Thaler (AK)

Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany; German Center of Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Daniela Berg (D)

Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany; Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany.

Andreas J Fallgatter (AJ)

German Center of Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany; Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.

Florian G Metzger (FG)

Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany; Geriatric Center, University Hospital of Tübingen, Tübingen, Germany; Vitos Hospital for Psychiatry and Psychotherapy Haina, Haina, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH